Identifying therapeutic targets for schizophrenia
There is a continual need to develop new therapies for neuropsychiatric disorders such as Schizophrenia, and identifying the underlying molecular processes remains challenging. Chadha et al. recently discovered a potential role for mTOR kinase activity disruption in Schizophrenia and further uncover...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2021-06-01
|
| Series: | Communications Biology |
| Online Access: | https://doi.org/10.1038/s42003-021-02270-3 |